Duorui Pharmaceuticals (301075.SZ) plans to establish Tibet Ruishengxiang Pharmaceuticals Co., Ltd.

TMT Finance and Economics APP news, Doray Medicine (301075.SZ) announced that, according to the needs of the company's operations and strategic development, in order to optimize the management functions of the company's headquarters, the company has established a wholly-owned subsidiary, Tibet Ruishengxiang Medicine Co., Ltd., with a registered capital of 2 million yuan.